Parkinsons & Huntington Disease

conferenceseries.com

4th World Congress on Parkinsons & Huntington Disease

August 29-30, 2018 Zurich, Switzerland

SCIENTIFIC PROGRAM SCIENTIFIC PROGRAM DAY 1 Wednesday, 29th August

08:30-09:00 Registrations

09:00-09:30 Introduction

09:30-09:50 COFFEE BREAK

09:50-11:50 KEYNOTE LECTURES Meeting Hall 01

MEETING HALL 01 11:50-13:10 Talks On: Parkinson Disease Epidemiology of Parkinsons

Neuromuscular Disorders

13:10-13:15 GROUP PHOTO

13:15-14:00 LUNCH BREAK

MEETING HALL 01 14:00-16:00 Talks On: Huntington Disease Risk Factors of Parkinson’s disease Pathophysiology and Pharmacology Diagnosis for Parkinson’s disease

16:00-16:20 COFFEE BREAK

MEETING HALL 01 (16:20-17:00) Parkinson’s disease: Complications

Visit: https://parkinsons.neurologyconference.com/ SCIENTIFIC PROGRAM DAY 2 Thursday, 30th August

09:00-10:30 KEYNOTE LECTURES Meeting Hall 01

10:30-10:50 COFFEE BREAK

MEETING HALL 01 10:50-12:50 Talks On: Mitochondrial Dysfunction

Insights and Therapeutics: Parkinson’s Disease Managing life with Parkinson’s Disease

12:50-13:35 LUNCH BREAK

MEETING HALL 01 13:35-15:55 Talks On: Neurosurgery Free Radicles and Aging in Parkinsons Novel Therapeutics Clinical Trials in Parkinsonism

15:55-16:15 COFFEE BREAK

Visit: https://parkinsons.neurologyconference.com/ 4th World Congress on Parkinsons & Huntington Disease

AUGUST 29-30, 2018 | ZURICH, SWITZERLAND

AGENDA

President and CEO, USA Gjumrakch Aliev Tampa,Florida, USA ofUniversity Juan Sanchez University, Oman Qaboos Sultan Musthafa Mohamed

analogues andmedicinalp Title: Neuroinflammation, Microglia andMast Cellsin the Pathophysiology of Characterization and development of a platform for the evaluation of nicotine of evaluation the for platform a of development and Characterization

South - Ramos

lants derived compoundslants asselectiveParkinson drugsin n a ivle i eio/eiwr or o vros well various Neuroscience and in Bioscience asFrontiers such of board editor/reviewer in involved an USA and Kluwer, & Wolters by published in Diseases Neurological Pharmacology, training get of Sates to United America. of resident permanent a USA is He Oman. to to moved further and moved he in USA NY, Island, Staten Research, Basic for Institute State NY in Neurosciences Then position Neuropharmacology. A/Prof in visiting I in University Annamalai is PhD his holding did He Australia. and Sydney, University, Macquarie ASAM, group, Oman Neuropharmacology University, Qaboos Sultan at Nutrition of Professor Associate an is Ph.D., Essa, Mohamed M. Dr.

Administration, and Leading Scientist in the Institute of Physiologically Physiologically of Institute the in of Sciences. Academy Russian Compounds, Active of Scientist Professor Leading a and as Administration, USA Georgia, Atlanta, Sc Health Gerontology, Neuropathology, Atlanta, Cardiovascular, of University the with appointment holds also He USA. Texas, Antonio, San Inc., Institute Research Aliev Gjumrakch Dr. Disease Huntington’s for ofExcellence Centre HDSA of the Director a is he Currently, Endowed Ellis Helen the holds Miami. of he where Tampa in Florida University South of University the at Neurology of Professor the at Disorders Movement in Fellow a as and Chicago of University the at Neurology in trained He Illinois. of University the from (M.D.) degree medical a and Chicago of University the Sanchez Dr. e s n editor an is He - ao rcie a hD i Pamclg ad hsooy from Physiology and Pharmacology in Ph.D. a received Ramos , MD, PhD, President “GALLY” International Biomedical Biomedical International “GALLY” President PhD, MD, , - in - chief for International Journal of Nutrition, Nutrition, of Journal International for chief Chair for Parkinson's Disease Research and is is and Research Disease Parkinson's for Chair ndia in Biochemistry specialized specialized Biochemistry in ndia , Biochemie, PLOS one, etc. one, PLOS Biochemie, ,

ience and Healthcare Healthcare and ience - known journals journals known .

SPEAKER SLOTS AVAILABLE

Psychotherapy, Portugal Academy ofInterpersonal Ivandro Soares Punjab, India University, Kapurthala, IKG Punjab Technical Atul Kabra

Italy Misericordia inUdine, della Santa Maria Stanislao D’Auria FollowImprove

Emerging ApproachEmerging AgainstParkinson Disease Interpersonal Psychotherapy Steering Stimulation AndSteering Diretional ReliableLeads, A Recent Concepts To

Monteiro -

Up In Implanted A Implanted UpPatients. In Preliminary Experience

of S members as i am repuated various well in as journals various in memeber have board article editorial as serving am I review journals. I nd research in India. 18 Rajasthan, and books Kota, Pd.D. 4 published the Pharmacy, in of Persuing Professor College Aooscite Kota and an Pharmacology, as working Pharmacology am India. i in Punjab, Presently Jalandhar, University, Masters Technical Punjab from Kabra, Pharmacology Atul Mr. congresses. international many in relator ad as involved della been has and journals reputed in worl papers Maria 8 than more he Santa Neuro 2008 of Neuromodulation, and Since Neuroscience of Medicine. Mis Department of at School Neurosurgeon Naples, Second from of completed has University 2008 in Neurosurgery in specialization took D’Auria Stanislao Dr. PT) Univ. Porto, Salazar, Biomédicas de Ciências Psychothe Interpersonal (www.emesaude.pt) Clinic PT) Minho, of (University Psychology Psyc Organizational Psychotherapy and Association) & Psychologists Psychology Institute Clinical Interpersonal in Psychotherapy Expert Psychotherapy) Interpersonal Interpersonal Certified for Society International the the by recognized and (by Psychotherapist Psychologist Clinical ericordia in Udine, Italy, Field s of interests are Functional Neurosurgery Neurosurgery Functional are interests of s Field Italy, Udine, in ericordia ociety of Ethnopharmacology of India. ofEthnopharmacology ociety

graduated in Medicine in 2003 at the age of 25 y. and y. 25 of age the at 2003 in Medicine in graduated rapy - –

- M.Sc. Cognitive Sciences & PhD in Clinical Clinical in PhD & Sciences Cognitive M.Sc. University Visitor Professor (ICBAS Professor Visitor University

one ad ietr f h Aaey of Academy the of Director and Founder oncology, neurovascular. He has published published has He neurovascular. oncology, -

Founder & Director of the EME Health EME the of Director & Founder

hology (Portuguese (Portuguese hology

Depart,emnt of of Depart,emnt –

Instituto Instituto -

SPEAKER SLOTS AVAILABLE

USA ofUniversity Kentucky, BingGuoying Neurodegeneration Caused By Exposure To Trichloroethylene (TCE) hypoxia in the 6 in the Qingdao Qingdao University, CollegeMedical of Junxia Xie China Qingdao Qingdao University, CollegeMedical of Jun Wang

Mechanism Of Action And Selective ExtentDopaminergicMechanism Of

- The Kv7/KCNQ channel Kv7/KCNQ XE991blocker nigral The protects - h efcs f 6 of effects The hydroxydopamine modelParkinson’s rat of disease. inducible factors.inducible

HA n rn eaoim n srcts r media are astrocytes in metabolism iron on OHDA journals. reputed in 30papers than Qingdao more has published She University. Qingdao in from pathophysiology and years physiology of 30 department the of of Professor age studies the postdoctoral at and PhD University her completed has Wang Jun been has and journals reputed in papers of repute. member board the 100 editorial an serving as than is more She published München. has Groβhardern, Klinikum o director and and Munich China of of University University Ocean Neurology, from of Department Physiology, PhD of Institute from studies her postdoctoral completed has Xie Junxia repute Journals of 2 member board editorial as an hasserving been more published has He Medicine. of College Kentucky, of University Neuroscience of Professor the is in He 1991. University York New from studies postdoctoral and 1988 in Medicine of School Rochester of University from PhD his completed has Bing Guoying Dr. f Institute of Brain Science and Disease in Qingdao University. She She University. Qingdao in Disease and Science Brain of Institute f

hn 1 ppr i rptd oras and journals reputed in papers 115 than

rm nvriy t ufl. h i a is She Buffalo. at University from dopaminergic neurons

ted by by ted

SPEAKER SLOTS AVAILABLE

Australia CowanEdith University, Ian James Martins China Qingdao Qingdao University, CollegeMedical of ShiLimin Amyloid betaAmyloid interactions inNeurodegenerativediseases of A HYDROCEPHALY TURKEY MODEL. Kırklareli, HYPOPHYSEALENDOCRINOPATHY Hospital, Turkey Hospital, Government Lüleburgaz Nurhat Handan Raziye

- type potassium channels

nui rssac ad hlseo dsoesai ivle α involve dyshomeostasis Cholesterol and resistance Insulin Ghrelin enhances excitabilityofnigral the neurons dopaminergic Ghrelin byinhibition

LIGHT MICROSCOPICALLIGHT EVALUATION OFACUTE AND CHRONIC

Lüleburgaz the at neurosurgeon a Hospital. Government as works she University Medicine.Now Ufuk of from from School years studies 24 postdoctoral of and age University the Mayıs at Ondokuz PhD his completed has Nurhat Dr.R.Handan METABOLISM. AND ENDOCRINOLOGY 2015 RESEA KUHN RICHARD the with Conferred (Nutrition). Science Championship Academic Fellow. (World as Winner Ratings and Standards for Agency International by Membership Sc (20). Academia.edu. with Academic and (USA) Board Advisory Science for Scientist Inc). Congress. (2017 Studies Clinical and Diabetes of Journal and (2014 Research Pub/MDPI Access Diabetes of Journal Open International for for Editor Chief the Editor/Reviewer as Appointed journals. an is Martins James Ian Dr. journals. reputed papers in 10 than more published has She physiology University. Qingdao in of pathophysiology and department the of Professor associated an is She University. Limin

Shi has completed her PhD at the age of 29 years from Qingdao Qingdao from years 29 of age the at PhD her completed has Shi ientific research citations accumulated to >3300. Lifetime Lifetime >3300. to accumulated citations research ientific PROCESSKAOLIN INDUCED IN H - - 2018), 2018), index

of 43, (ResearchGate STATs (23), Mendeley STATS STATS Mendeley (23), STATs (ResearchGate 43, of eerh n Reviews and Research

07 i Daee ad Medical and Diabetes in 2017) Neuroscience : - 2018) - yuli and Synuclein . BIT Member (BIT (BIT Member BIT .

RCH AWARD RCH (2016 - 2018) 2018) - SPEAKER SLOTS AVAILABLE

Japan Nara Medical University, Kazue Sawami Korea Clinic, SouthMedicine Young JinKorean & Daejeon University Byung systematic reviews

Germany University Kedzior, Ilkay Kaplan Karina Karolina

- Jun Park Jun Neurodegenerative DisorderNeurodegenerative The effects of Tai of effects The Chionwell Validation ofmethods of working

of Bremen, of

Bremen, of University Germany. the at student Psychology of Bachelor semester Ilkay Germany. Bremen, of University the at Psychology in Methods Research of Professor Associate an is Kedzior Karolina Karina Dr. W the in 2017 Who Who’s Marquis the in listed was He Society. Disorder published Movement the of member a has is and journals reputable in He disease Parkinson’s 1995. since disorders movement his and Clinic, Medicine specialty Korean Jin clinical Young Daejeon, a University, opened has Daejeon He Medicine, Korea. Korean South of College the at degrees Byung Dr. elderly. the with communication bidirectional attempts method the developed of transmission Video Association. Dance Studio Street Japan the with collaboration a is This research nursing.co address. following atthe beviewed can group system. control remote equipment information intervention the is developed being currently Research people. elderly in dementia of theprevention is study recent and the science, health is a acquisition University. Medical atNara a professor is Sawami Kazue - being in being in A Parkinson’s disease: ofsynthesis - 2018. 2018.

- m/katsudou.php - memory training u Pr cmltd i PD n Kra Dco i Medicine in Doctor Korean and PhD his completed Park Jun

by artificial intelligence, and support of the elderly by the bythe the of elderly support and intelligence, artificial by a be te ramn o P of treatment the been has

http://www.g

Results of their research research of their Results arkinson’s disease and and disease arkinson’s

Her Ph.D. Her Ph.D. utpe aes on papers multiple

- Kaplan is a 4th 4th a is Kaplan rd in orld

SPEAKER SLOTS AVAILABLE

KuwaitKuwait University, Sana Al South Korea Chosun University, Chansik Hong

Through GPR109A Huntington’s Disease Bustan Parkinson Disease: A Study of Public Disease:AStudyofPublic Awareness inKuwaitParkinson icn teuts nlmaoy yoie peuain n D Mediated PD in Upregulation Cytokine Inflammatory Attenuates Niacin Increased TRPC5 Contributes to StriatalNeuron Glutathionylation Increased Lossin

Psychometric Evaluation using Communication Disorder App” in the the in App” Disorder Communication Human of Journal International using Evaluation Psychometric 2017, December she In Voice. of Journal the in Handicap” Voice of Perceptions Teachers' “Kuwaiti published Albustan Dr. May,2017, In clinics. private and schools public hospitals, Florida in were practicums and internship clinical U Professions, Health and Health Public Sciences, of Hearing College and Language Speech, of Department the from Ph.D. earned her She University. Kuwait Sciences, Life of College Sciences, Disorders AlBustan A. Sana neurodegenerative diseases in patients. in diseases neurodegenerative and injury CNS in inflammation of role studying on focuses work recent His mice. and rats in models TBI and SAH MCAo, various including models stroke on animal worked has He years. of number for amelioration its and injury has He research. develop clinical to of campus, him areas allowed novel University have departments, Augusta and the colleges several with spanning collaborations current His neural repair. and system nervous the to trauma include research his of focus The at Dept. journals. reputed in channels ion regarding Physiology of professor He School. associate Medicine University an Chosun is He Medicine. Seoul of from College years 33 of University age National Seoul from the studies postdoctoral and at University National PhD his completed has Hong Chansik

published” Towards a Standard Arabic System Usability Scale: Scale: Usability System Arabic Standard a Towards published”

is a young researcher in the Department of Communication Communication of Department the in researcher young a is – Computer Interaction. Computer

has published more than 25 papers 25 than more published has

en nae i te il o CNS of field the in engaged been

iest o Foia Her Florida. of niversity

SPEAKER SLOTS AVAILABLE

TURKEY Duzce University, İlknur SuidiyeYorulmaz U.S.A &Science, Medicine International Instituteof Alain L.Fymat

USA Phoenix, Arizona85054 Clinic Mayo inArizona, Joseph I.Sirven Scenarios Emergencies .

Anesthetic Workshop on fromEpilepsy Diagnosis IndividualWorkshop Seizure Seizure to

Approach The Of ParkinsonDisease: Drug Choices And Unexpected

Journals. scientific of orEditor twelve Editor Editor and institutions, several of member Board a a is extensively has He venues. industrial and governmental professional, He academic, international barriers). protective lecture brain and publications) scholarly (~350 published the across delivery and drug genetics/epigenetics/ecogenetics; nanomedicine; between interface nanobiotechnology; the at lie interests scie research current His Universities. European and U.S. several at Physics and Medicine, Care Critical Medicine (Oncology), Radiation M Sciences, Radiological of Radiology, of Institute Professor formerly International the at Professor and President/CEO current the is He Angeles. Los at California of University Paris and Bordeaux of Universities the at educated Fymat L. Alain Dr. the of Chair previous Editor Arizona; Epilepsy.com, and Arizona; in in Clinic Mayo Clinic at Neurology Mayo of Department at Epilepsy the of Director of is Sirven Division Dr. Pennsylvania. of University the at fellowship neurophysio clinical a and State Minnesota of University Louisiana the the at degree M.D. at residency neurology a completed He an Louisiana. Orleans, New in University by followed biology in University Sirven Joseph has She . journals in papers 20 than more published anesthesia. geriatric and in anesthesia surgery techniques obesity , monitorisation anesthesia neuroanesthesia, are interests Her 2012. since Professor Associate an as TURKEY Duzce, Departhment, Reanimation and University,Anesthesiology Duzce in working been has She Medicine. of School University Duzce from studies postdoctoral and TURKEY University, has YORULMAZ Suidiye İlknur nce and medicine (neurological disorders; precision medicine; medicine; precision disorders; (neurological medicine and nce the American website for the Epilepsy Foundation Epilepsy for the website American the

completed his undergraduate BS degree at Georgetown Georgetown at degree BS undergraduate his completed

is a medical a is - physical scientist and an educator who was who educator an and scientist physical completed her PhD at 1998 from Akdeniz Akdeniz from 1998 at PhD her completed

dcn & cec. e was He Science. & edicine - Sorbonne, France, and the the and France, Sorbonne, d in several national and and national several in d logy in epilepsy EEG EEG epilepsy in logy - in - Chief, Honorable Honorable Chief,

- in - Chief of of Chief

SPEAKER SLOTS AVAILABLE

Riyadh Abdul Prince Mohammed Bin AMAL MOHAMMED USA Jacksonville, HSC Florida of University Bautista Ramon Egypt Helwan University, Alaa EldeenMahmoud

Aziz Hospital, Aziz Hospital, - KSA Epilepsy Wellness: Beyond Diagnosis, Beyond Therapy Neuropsychological assessment for Epilepsy assessment for Neuropsychological Patients Automatic detection ofepilepticAutomatic dischargesinlong EEG recordings

clinical in epilepsy with of individuals condition the psychosocial are interests research His e Discovery. of book, Century the A edited and Epilepsy: journals reviewed peer in extensively published has He University. Yale and University, Emory Louis, St. University Washington complet and Philippines the of University the from also graduate a is He is Program. Epilepsy he Comprehensive the of where Director Jacksonville Center Sciences Health Florida of University Dr. in EEG signal and preventing the Seizure Evolution by Vagus Nerve Nerve Vagus by Evolution Seizure the preventing system. loop feedback closed and a smart using Stimulation signal EEG in wav Epileptic of Detection Automatic on focused is study doctoral His (FES). Stimulation Electrical Functional the using disease Foot Drop the treat I .....). MEG, to Stimulation Nerve Electrical on based device medical smart a implemented ECG, (EEG, Biosignal in especially processing Engineering Biomedical in interested is he general, In journals. reputed in papers many published has He Engineerig. of Faculity “MSc Dr. University. Currently, she is working as Neuropsychologist at Prince Prince at Neuropsychologist rep as working Abdul is Bin Mohammed she Oxford at Currently, WADA doing is University. who neuropsychologist with attended and test, neuropsycho with training got Cognitive Human years, six for Hospital Guard National in team epilepsy with working in was She Science of from years 30 of Master age the at Neuropsychology her completed has Mrs.Albluwi pilepsy and neurophysiology with a focus on understanding and improving improving and understanding on focus a with neurophysiology and pilepsy uted journals uted Alaa Eldeen Mahmoud Helal Hela Helal Mahmoud Eldeen Alaa Bautista is Professor and Associate Chairman of Neurology at the the at Neurology of Chairman Associate and Professor is Bautista ”

from Cairo University and doctoral studies from Helwan University University Helwan from studies doctoral and University Cairo from

- Aziz Hospital KSA. She has published two papers in in papers two published has She KSA. Hospital Aziz logist form John Hopkins University on WADA WADA on University Hopkins John form logist

hs “MSc his n l has l ed his post graduate training in in training graduate post his ed

The University of Edinburgh of University The completed his Master’s degree degree Master’s his completed ”

e a dsge and designed has he

eforms eforms . SPEAKER SLOTS AVAILABLE

Himachal Pradesh,India CSIR Arindam Ghosh of Medicine, Curacao SchoolAvalon University Abraham RatnaJoseph

Orpington, BR6 8ND Foundation Trust, Kings Hospital, College Princess Royal University Divya Tiwari ofpentylenetetrazolemodel seizure induced

Managing Epilepsy in Older by Epilepsyin People Managing Neural tube Defects tube Neural Exploring the anti the Exploring

seizure ofpotential PI3Kselective inhibitorinzebrafish and medicine geriatric in research service delivery outcomes include interest other Her adults. older in epilepsy of review a published recently has She adults. older a speedy for neurology’ age ‘old in clinic new a established has She disorders. in movement and neurology age interest old special has She Trust. Foundation Hospital Bournemouth Royal Divya Indian of Member life a is He (2010). P Bengal West Darjeeling, Bengal, North of University the at Pharmacy, of Bachelor in position first securing for Pharmacy Graduate Medal University the of awarded also was He 2010. Pharmacy, of Master during basis f Council India the All by on (GPAT) Test Aptitude Fellowship Research awarded was He (2012). Sikkim Gangtok, University, Technology Sikkim at (Pharmaceutics) Pharmacy and Science of Department ( the DST by awarded sponsored was PhD, pursuing He India. Pradesh, Himachal CSIR from PhD Mazumder Ghosh Arindam with abroad and IndiaJournals of Anatomy and Research in Universities Medicalpresentations and Publications Various i in TeachingExperience of years Medical 6 than in more Masters has and University, India his SVIMS completed at Anatomy has and University Missions Vinayaka Medicine, HumanCuracao, of is aPhD Scholar School thein the department University of the field Avalon of in Faculty department,of Professor Function Assistant and Structure Nayakanti, Joseph Ratna Abraham Mr S) Gvrmn o Ida 21) H scrd is psto i Mse of Master in position first secured He (2013). India of Government DST), harmacological Society (LM (LM No. Society harmacological

Tiwari is consultant physician in Geriatric and General Medicine at The The at Medicine General and Geriatric in physician consultant is Tiwari Geriatricians: whereare we today? -

Institute of Himalayan Bioresource Technology, Palampur, Palampur, Technology, Bioresource Himalayan of Institute

is a Senior Research Fellow, currently pursuing pursuing currently Fellow, Research Senior a is n various International conferences and Medical -

LA - ssmn o nuooia polm in problems neurological of ssessment 306).

or Technical Education (AICTE) (AICTE) Education Technical or - INSPIRE Fellowship for for Fellowship INSPIRE Medicineat

SPEAKER SLOTS AVAILABLE

USA Northwestern AttarianHrayr MD China S Ni Hong

oochow developmental s ignaling pentylenetetrazole mice in convulsant effectsof methadone seizure onclonic induced by

Sciences,Tehran, Iran. Sciences,Tehran, Medical of University Tehran Kazemi Soheil Semiology & Pathophysiology ofEpilepsySemiology

University Effect of Effect of The role ofNMDA signaling role The intolerance, receptor/NO dependence& p athway on University

seizures ,

inc / inc /

, h l ippocampal ipid / ipid

a utophagy won has teachi He grants. three got and projects research 30 in participated and textbooks. three Russia Moscow and China and Shanghai including internationally and nationally chapters 20 papers, reviewed Rochester of respec University Center Medical County Hennepin and at medicine sleep and epilepsy in fellowships and He Syracuse in University University. Medical Upstate at Neurology in residency completed Northwestern at fellowship g sleep and medicine sleep a currently is Attarian Dr regenerat disorders mood and Alzheimer , dementia stroke, convulsion, about in study is interested now.he until university medical of tehran department pharmacology to jointed has 25(2016). he studied in golestanuniversity of medical science and then he of age atthe doctorate inPhysician has graduated Roodsari Soheil Kazemi microcirculation of society Chinesecouncil the jou of member 60 a now than is developmental neuroscience. He more published has Soochow He Research, ClinicalUniversity. Pediatric of Institute Science, Brain of Division the of lead the professor and a is He 1995. since epilepsy and palsycerebral PediatricNeurologist with Ni Hong, Ph.D., works in the Children’s Hospital of Soochow University (China) as autd ih M i 19 fo Aeia Uiest o Biu and Beirut of University American from 1992 in MD a with raduated ng awards. - m ediated ive

mossy p .

lasma lasma maininterest Pediatricin neurological rehabilitation,

rfso o nuooy n mdcl ietr of director medical and neurology of professor fiber sprouting

m embrane embrane

tively.

i nl rils any with mainly articles rnal He has Published 70 peer peer 70 Published has He ntegrity

i nduced by

He has lectured lectured has He

SPEAKER SLOTS AVAILABLE

BCPP PharmD, BCGP, PhD, MarvanovaMarketa

Medicine, SchoolYale University of Lawrence S.Hsieh seizure inTuberous Sclerosis Complex and Focal Cortical Dysplasia Missouri, USA Missouri, Institute, Neuroscience Bloch Marion Luke’s Saint The N.Boutros Nash

Presentation on: Epilepsy Spectrum inPresentation Disorders Psychiatry: anold Carbamazepine Using cutting edge toadvanceUsing cutting animal model ourunderstanding ofintractable

USA

- related An

tiepileptic Drugs: Are They All the Same? the All They Are Drugs: tiepileptic Dr. Boutros is considered to be the leading authority on the clinical clinical the on authority leading the be to utiliza considered is Boutros chapters. Dr. book numerous and books 8 to addition in both journals international in and certified national in papers reviewed peer board 210 than more published has is Boutros He 1974. n in specializes in and neurology and Bloch psychiatry medicine Marion of Cairo from College graduated Luke’s He University Missouri. Saint City, Kansas Behavioral in the and Institute Neuroscience Memory at the of clinics Director Neurology/Neuropsychiatry currently is MD Boutros, Nash

geriatrics and neuropsychiatry in is expertise at research and clinical with academician neuropharmacology in North at traineeship fellowship research also Vanderbi medical She Finland. a Eastern of Ph.D. completed a University as the well as from Republic) (Neuropharmacology) (Czech University Charles the from degrees Pharm.D. M.S.Pharm., completed has She Pharmacist. Geriatric and Pharmacist Psychiatric Certified Board a is She Pharmacy. of School University State Dakota North at Professor Associate Dr. Roche at discovery drug Nature CNS and epilepsy in li years passion five Neuroscience His targets spent Pharmaceuticals. Lawrence druggable Nature training, PhD investigating his including to Prior Communications. journals, reputable p has a He and awardee. award, Whittemore investigator H. young Vicky GRASS the of recipient a is of He Medicine. University from 2012 in of School Yale from training postdoctoral Neuroscience and Medicine of School Connecticut in PhD his received Lawrence Marvanova serves as the Chair of the Pharmacy Practice Department and and Department Practice Pharmacy the of Chair the as serves Marvanova tion of electrophysiology in the practice of clinical psychiatry clinical of practice the in electrophysiology tion of

lt University School of Medicine and a Parkinson’s disease disease Parkinson’s a and Medicine of School University lt

- western University. She is an experienced clinician and and clinician experienced an is She University. western es in developing therapies for intractable intractable for therapies developing in es and Ph.D. (Pathological Neurobiochemistry) Neurobiochemistry) (Pathological Ph.D. and bihd oe hn 3 aes in papers 13 than more ublished europsychiatric conditions. Dr. Dr. conditions. europsychiatric

- new concept

SPEAKER SLOTS AVAILABLE

EGYPT Ain ShamsUniversity, Salah Hamada Montreal Canada McGill University Rapita NareshSood University atProfessor Stanford Clinical Assistant Laurice Yang

Role ofthemTOR signaling pathway Epilepsy in specifically in eIF4ebp2 KOmice Diagnosis and Treatment andTreatment Dystonia Diagnosis for

Disconnection Disconnection procedures forthemanagementof drug resistantepilepsy

disorders including Parkinson’s disease, atypical parkinsonian disorders, disorders, parkinsonian disease. Huntington’s and Tremor, Essential atypical disease, Parkinson’s including of disorders University the Bronstein. at Jeff board fellow Dr. under disorders Angeles Los movement in California a as training clinical curriculum. education student/resident medical yea entire the spent and Resident Chief Neuroscience appointed was she where California Southern of University the at residency neurology her completed and Vermont of University the from degree medical her obtain California Southern of h University the received she the where at Administration Health in degree Berkeley. in California of University the at Biology Cell Molecular in degree bachelor’s her received Yang Laurice Ex the is He Brno. University Shams Ain neurosurgery, and Germany UK, USA, in Surgery Shams Epilepsy in conferences and courses workshops, postdoctoral and Ain University Shams Ain from years neurosurgery, 33 of age the at PhD his of completed has He professor surgery. tumor associate Brain and Epilepsy in interest special with Egypt an , University is Hamada Salah mTOR pathway which is a new perspective fortheRescue futuredirectionto new therapy a meofgiving epilepsy.Epilepsyis projecton my Also, Year. one for fellowship award Internal McGill a is Fellowship which Strauss Edith alsohas reputedjournals andinpapers published 8 has She Sonenberg. Nahum Dr. of laboratory the University In McGillCenter ResearchPostdoctoral Cancer Goodman her from Presentlystudies doing and RapitaNareshSoodDr. - etfe neurol certified

ogist, specializing in the diagnosis of movement movement of diagnosis the in specializing ogist, has completed her PhD from UniversityfromIsraelHaifacompletedPhDhasof her igh honor as a Dean Merit Scholar. Merit Dean a as honor igh

Subsequently, she earned a master’s master’s a earned she Subsequently,

- director of Department of of Department of director received the Richardandreceivedthe

Dr. Laurice Yang is a a is Yang Laurice Dr.

h cmltd her completed She rvmig the revamping r

She went on to to on went She

SPEAKER SLOTS AVAILABLE

Huntington of neurodegeneration in neuronmodels disease intercellular transport of mutant Huntingtin London College King’s Science, Pharmaceutical of Institute R.C.Hider 33458 Jupiter,Institute, The Scripps Research SubramaniamSrinivasa Andrey S.Tsvetkov School at HoustonSchool at McGovern Medical ofThe University Texas Inhibiting sphingosine huntingtin kinase mutant Inhibiting 2mitigates Rhes, a protein aprotein implicated Rhes, in Huntington nanotubes disease, promotes and

Iron chelation Iron as apotential therapy for thetreatment ofParkinson’s disease

Florida

Ain

- clinical therapeutics clinical dise neurodegenerative in networks signaling halting or modifying of characterization and identification on focuses of lab Our progression. disease capable therapies no currently are there decades, to ability our While large. at world the and community scientific the both facing problems significant most the of one becoming quickly are diseases Neurodegenerative lios t hcg. e s rcpet f w awards two of recipient research. disease Huntington for Foundation Disease a is Neurological He of Chicago. at Institute Illinois Gladstone the California, of University the from biophysics and physiology in PhD a earned He Disease. of University the at completing after 2013 in of department department the joined the Tsvetkov Dr. Houston. of at Center Science University Health in Texas the School, professor Medical McGovern assistant at Anatomy an and Neurobiology is PhD, Tsvetkov, Andrey of ironoverload. the for treatment worldwide used hydroxy now is Deferiprone application. result, clinical for potential possessing as identified a transport As overload. and iron of structure treatment membrane by the for chelators iron on oral iron novel of development the to of led work has mechanisms absorption His the cells. and mammalian microorganisms in processes biological uptake in lecturer siderophore a with worked has was He he University. Essex this at chemistry to Prior 1987. since worked has he where London, College King’s at chemistry medicinal of professor is Robert

provide symptomatic relief has increased over the past few few past the over increased has relief symptomatic provide

his postdoctoral training with Dr. Steven Finkbeiner Finkbeiner Steven Dr. with training postdoctoral his

- ases with a goal of developing developing of goal a with ases induced

pyridinones have been been have pyridinones

from the Hereditary Hereditary the from

- based

iron

SPEAKER SLOTS AVAILABLE

EGYPT Kambiz Hassanzadeh models: in knowledge therapeutic strategies andfuture Joanne Trinh Germany ofUniversity Luebeck India University, Lucknow, MedicalKing George’s Shivani Pandey

Neuromodulatory effect of effect Parkinson’sNeuromodulatory (Bramhi) in diseaseBacopa monnieri The Role of Oxidative Roleof The Stress InflammationParkinson’s & in Currentdisease: Genetic Genetic modifiers ofParkinson’s disease -

vivo andin

vitro vitro

evidences strategies involve prescription of dopamine agonist drugs which turn turn which drugs agonist dopamine use prolonged after of ineffective prescription involve strategies no has disease The impairment. motor and cognitive to leading thereby neurons, dopaminergic of death selective by characterized disease, neurodegenerative common a is disease Parkinson’s common genetic cause of PD cause of genetic common p.G2019S LRRK2 by exemplified as asymptomatic, remain some even and distinct vastly are carriers mutation of features clinical although identified been have genes many in mutations Pathogenic genetics. to focus genome of large and results studies linkage However, negligible. by was caused mainly estimates be to thought late of heritability the and factors originally environmental was (PD) disease Parkinson researches on antioxidant agents on animal models of Parkinson’s disease of Parkinson’s models animal on agents onantioxidant researches disease. Parkinson’s especially diseases, publications. neurodegenerative of nature 60 molecular on research than doing in interested more been has he years, with recent During field Neuroscience in researches teaches doing He Sciences. Medical neuroscience and of Pharmacology University Kurdistan at center research molecular and cellular of head & professor associate is Hassanzadeh Kambiz

- scale next scale

courses to medical and PhD students and and students PhD and medical to courses - generation sequencing have shifted the shifted have sequencing generation absolute cure yet; all the therapeutic therapeutic the all yet; cure absolute - onset disease based on twin on based disease onset - wide association, association, wide -

the the

He also also He most most

SPEAKER SLOTS AVAILABLE

polyglutamine of pathway expansionandtheexpression ubiquitin and autophagic

Turkey Hospital and Training Research Therapy Rehabilitation PhysicalIstanbul Gülten Özdemir

New Delhi University, Jawaharlal Nehru LifeSchool of Sciences, MUKUL JAIN Korea and Science Technology Pohang Universityof & Bi of Division Biosciences Kim KT Aggregation of CAG repeats in D.discoideum varies with the length of of withlength the varies inD.discoideum of CAGrepeats Aggregation otechnology,

A caseofthyroid hemiagenesis diagnosed after essential tremor

VRK2 mRNA stability andVRK2 mRNAstability PolyQ

India

former age, but the mechanism of its degradation and its relationship to to relationship its and degradation its unclea disease remain of mechanism the but an age, at disease former cause and rapidly more aggregate repeats polyQ longer with Proteins neurons. affected polyQ of cytoplasm and of nucleus the in production aggregates forms the is disorder repeat CAG of hallmark A polyQ protein aggregation and cytotoxicity and aggregation protein polyQ TCP containing (VRK2) 2 vaccinia to due accumulate aggregates polyQ that found was it Recently, (HD). disease Huntington's including disorders, cause neurodegenerative expansion (polyQ) polyglutamine abnormal with proteins Misfolded by characterized disorder congenital rare, a gland thyroid the of alobe nondevelopment is hemiagenesis(TH) and growth for required mainly in hormone Thyroid life. of quality the decrease life a glu not blood low is tremor Essential condition the fatigue, trigger may drinks caffeinated temperature, stress, emotional ipsilaterally, Physical initially. and involved seen are hands commonly usually and is movement with worsens tremor(ET) Essential diagnosis. clinical tremors rhythmic involuntary causing disorder neurological a is tremor(ET) Essential

the development of organs including brain and skeletal systems. Thyroid Thyroid systems. skeletal and brain including organs of development the

(4 - - mediated degradation of degradation mediated hetnn cniin u i te ypos r svr, t may it severe, are symptoms the if but condition threatening - 12 Hz) and mostly seen in adults with ages 40 or more. ET is a is ET more. or 40 ages with adults in seen mostly and Hz) 12 - huntingtin aggregation - (C) wih a a esnil oe n h peeto of prevention the in role essential an has which (CCT), 1 r

TCP - 1 ring complex (TRiC)/Chaperonin complex ring 1

cose level, alterations in in alterations level, cose

symptoms - related kinase kinase related

repeat that that repeat

SPEAKER SLOTS AVAILABLE

Failure, Hospital, TurkeyHospital, Yunus EmreState Ari Semra Turkey Neurology Tarsus State Hospital BurcuSelver Tellioğlu REPORT University Gyeongsang National ofLifeInstitute Sci ResearchMedicine, ofVeterinary College Department of Anatomy, Phil expression inexpression braintissue -

Ok Koh Clinical And Neuropsychological Study Of Natural AndNeuropsychologicalStudyOf Clinical CourseOfLightCognitive PARKINSONISM SECONDARY TO METASTATİCTO SECONDARY BRAIN PARKINSONISM Alzheimer Disease And

: Quercetin prevents the ischemic injury , Korea

ence,

Parkinson Dementia Parkinson er Ai a cmltd e PD t h ae f 5 er fo Aaük and Atatürk from years . 25 Hopital Resouce of age the at PhD her completed has Ari Semra to examine the courses of clinical factors of courses clinical the examine to and dementia to cases these of ratio transformation the determine to series; therapeutic any Alzheimer of of free courses cases natural the examine to is study this of Objective The repute. ser and has been journals reputed in papers 180 than more has published She University. National Gyeongsang Medicine, Veterinary of of College professor the is She USA. Baltimore, at Maryland of University from studies postdoctoral and University National Phil - Ok Koh has completed her PhD at the age of 28 years from Gyeongsang years from of 28 age at the PhD her has completed Koh Ok

- induced decrease of thioredoxin

procedure and with neuropsychological test test neuropsychological with and procedure ving as an editorial board member of of member board an editorial as ving

TUMOR: ACASETUMOR:

SPEAKER SLOT AVAILABLE Switzerland Attractions

of Fine Arts Chillon Castle Zurich kunsthaus Museum

Lake Lucerne Bahnhofstrasse

Zermatt Limmatquai &

Rathaus Town Hall

Rhine Falls

Swiss National Park

Visit: https://parkinsons.neurologyconference.com/ Glimpses of Parkinsons Conferences

Visit: https://parkinsons.neurologyconference.com/